ACTIVE

LOUVIMAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-40,9 k €

-184.2% YoY

Gross margin

281,2 k €

+1.1% YoY

Equity

106,8 k €

-27.7% YoY

Workforce

2,9 ETP

+3.6% YoY

What does LOUVIMAR do?

LOUVIMAR is a Private limited company incorporated in 1998. Its registered office is in Perwez. It employs on average 2,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0463.466.493

Incorporation

29/05/1998

Legal form

Private limited company

Registered office

Rue de la Chapelle 35
1360 Perwez · WallonieSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Average workforce

2,9 ETP

Joint committees (1)

Signals

Healthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	281,2 k €	+1.1%	278,2 k €	+0.5%	276,7 k €	-2.0%	282,2 k €	+5.5%	267,5 k €	+5.4%	253,8 k €	-12.6%	290,4 k €	+26.9%	228,8 k €	+9.2%	209,5 k €	-13.8%	243,2 k €	-17.7%	295,5 k €	+11.3%	265,5 k €	+3.5%	256,4 k €	+5.8%	242,4 k €	-11.4%	273,6 k €	-5.1%	288,4 k €	+27.2%	226,7 k €	-7.6%	245,4 k €	+20.2%	204,2 k €
EBITDA	-11,7 k €	-404%	3,9 k €	-78.9%	18,3 k €	-21.3%	23,3 k €	-33.8%	35,2 k €	+9.0%	32,3 k €	-56.3%	73,9 k €	+176%	26,7 k €	-1.1%	27 k €	+53.4%	17,6 k €	-80.7%	91,3 k €	+28.4%	71,1 k €	-8.7%	77,8 k €	+68.4%	46,2 k €	-44.6%	83,5 k €	-4.6%	87,5 k €	+46.9%	59,6 k €	-21.6%	76 k €	+20.2%	63,2 k €
Operating result	-37,8 k €	-198%	-12,7 k €	-365%	4,8 k €	-63.7%	13,2 k €	-36.0%	20,6 k €	+227%	6,3 k €	-88.7%	56 k €	+336%	12,8 k €	+248%	-8,7 k €	+46.6%	-16,3 k €	-121%	76 k €	+36.1%	55,9 k €	-10.9%	62,7 k €	+84.9%	33,9 k €	-59.5%	83,7 k €	+29.6%	64,6 k €	+112%	30,5 k €	+272%	8,2 k €	+293%	2,1 k €
Net result	-40,9 k €	-184%	-14,4 k €	-337%	6,1 k €	+6666%	89,8 €	-99.0%	9,2 k €	+1136%	-891,2 €	-103%	32,3 k €	+2512%	-1,3 k €	+92.3%	-17,5 k €	-154%	32,3 k €	-20.9%	40,8 k €	+43.4%	28,5 k €	-2.9%	29,3 k €	+188%	10,2 k €	-76.5%	43,3 k €	+33.1%	32,5 k €	-70.2%	109,2 k €	+265%	-66 k €	-40.1%	-47,1 k €
Balance sheet
Equity	106,8 k €	-27.7%	147,7 k €	-8.9%	162,1 k €	+3.9%	156 k €	+0.1%	155,9 k €	+17.5%	132,7 k €	-0.7%	133,6 k €	-14.5%	156,2 k €	-0.9%	157,6 k €	-10.0%	175,1 k €	+22.6%	142,7 k €	+17.1%	121,9 k €	+30.5%	93,4 k €	+11.1%	84,1 k €	+13.8%	73,9 k €	+46.0%	50,6 k €	+180%	18,1 k €	+120%	-91,2 k €	-262%	-25,2 k €
Total assets	620,3 k €	-3.4%	642,3 k €	-7.2%	691,9 k €	+6.5%	649,4 k €	+12.6%	576,6 k €	+15.1%	500,7 k €	+7.8%	464,3 k €	+0.2%	463,5 k €	-2.8%	476,8 k €	-6.0%	507,4 k €	-1.2%	513,4 k €	-0.6%	516,7 k €	+5.8%	488,2 k €	-7.5%	527,7 k €	-7.6%	571,2 k €	-3.6%	592,3 k €	-16.6%	710,5 k €	-38.8%	1,2 M €	-6.9%	1,2 M €
Cash	163,9 k €	-14.3%	191,4 k €	+12.0%	170,9 k €	-31.1%	248,1 k €	+28.5%	193,1 k €	+187%	67,2 k €	+71.4%	39,2 k €	-20.7%	49,5 k €	+615%	6,9 k €	-70.1%	23,1 k €	+43.7%	16,1 k €	-38.1%	26 k €	+279%	6,9 k €	-2.2%	7 k €	+57.8%	4,4 k €	-50.2%	8,9 k €	-91.4%	103,8 k €	+127%	45,7 k €	+91.2%	23,9 k €
Debts	513,4 k €	+3.8%	494,6 k €	-6.6%	529,8 k €	+7.4%	493,4 k €	+17.3%	420,6 k €	+14.3%	368 k €	+12.4%	327,5 k €	+6.6%	307,2 k €	-3.7%	319,1 k €	-3.7%	331,4 k €	-9.1%	364,5 k €	-6.2%	388,4 k €	-1.5%	394,2 k €	-3.4%	407,9 k €	-11.2%	459,5 k €	-8.8%	504,1 k €	-22.6%	651,1 k €	-46.5%	1,2 M €	-4.4%	1,3 M €
Other
Workforce	2,9 ETP	+3.6%	2,8 ETP	+3.7%	2,7 ETP	-3.6%	2,8 ETP	+3.7%	2,7 ETP	-3.6%	2,8 ETP		–		–		2,8 ETP	0.0%	2,8 ETP	0.0%	2,8 ETP	0.0%	2,8 ETP	+12.0%	2,5 ETP	-10.7%	2,8 ETP	0.0%	2,8 ETP	0.0%	2,8 ETP	0.0%	2,8 ETP	0.0%	2,8 ETP	+16.7%	2,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 8 ended

Active mandates

Pierre Ancia

Director

Active

Ended mandates

Egide DOZOT

Director · since 24 novembre 2020

Ended

FINANCIA PHARMA

Manager · since 15 décembre 2018 · 0832.300.679

Represented by Pierre ANCIA

Ended

Egide DOZOT

Manager · since 24 novembre 2000

Ended

Pierre ANCIA

Director · since 29 mai 1998

Ended

At this address

Other companies at this address

Company	CBE no.
FINANCIA PHARMA● Active	0832.300.679
PHARMACIE DE LA CHAPELLE● Active	0453.011.081
Pharmacie de la Linière● Active	0846.065.375

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	29/08/2025	13/08/2024	09/10/2023	29/08/2022	16/09/2021
General meeting	14/05/2026	08/05/2025	09/05/2024	30/08/2023	23/06/2022	24/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	14/05/2026	30/06/2026	French	PDF
Abridged model	31/12/2024	08/05/2025	29/08/2025	French	PDF
Abridged model	31/12/2023	09/05/2024	13/08/2024	French	PDF
Abridged modelCorrection	31/12/2022	30/08/2023	09/10/2023	French	PDF
Abridged model	31/12/2022	30/08/2023	01/09/2023	French	PDF
Abridged model	31/12/2021	23/06/2022	29/08/2022	French	PDF
Abridged model	31/12/2020	24/06/2021	16/09/2021	French	PDF
Abridged model	31/12/2019	25/06/2020	21/08/2020	French	PDF
Micro model	31/12/2018	27/06/2019	30/08/2019	French	PDF
Micro model	31/12/2017	24/05/2018	10/06/2018	French	PDF
Abridged model	31/12/2016	22/06/2017	11/08/2017	French	PDF
Abridged model	31/12/2015	23/06/2016	03/08/2016	French	PDF
Abridged model	31/12/2014	25/06/2015	26/08/2015	French	PDF
Abridged model	31/12/2013	26/06/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	05/06/2013	28/06/2013	French	PDF
Abridged model	31/12/2011	28/06/2012	16/08/2012	French	PDF
Abridged model	31/12/2010	23/06/2011	12/08/2011	French	PDF
Abridged model	31/12/2009	24/06/2010	14/09/2010	French	PDF
Abridged model	31/12/2008	25/06/2009	30/09/2009	French	PDF
Abridged model	31/12/2007	18/07/2008	29/08/2008	French	PDF
Abridged model	31/12/2006	29/06/2007	24/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 8 ended

Active mandates

Pierre Ancia

Director

Active

Ended mandates

Egide DOZOT

Director · since 24 novembre 2020

Ended

FINANCIA PHARMA

Manager · since 15 décembre 2018 · 0832.300.679

Represented by Pierre ANCIA

Ended

Egide DOZOT

Manager · since 24 novembre 2000

Ended

Pierre ANCIA

Director · since 29 mai 1998

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates09/02/2024
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Capital / shares08/08/2007
CAPITAL, ACTIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-40,9 k €↓
2024
Annual accounts 2024-14,4 k €↓
2023
Annual accounts 20236,1 k €↑
2022
Annual accounts 202289,8 €↓
2021
Annual accounts 20219,2 k €↑
2019
Annual accounts 2019-891,2 €↓
2018
Annual accounts 201832,3 k €↑
2017
Annual accounts 2017-1,3 k €↑
2016
Annual accounts 2016-17,5 k €↓
2015
Annual accounts 201532,3 k €↓
2014
Annual accounts 201440,8 k €↑
2013
Annual accounts 201328,5 k €↓
2012
Annual accounts 201229,3 k €↑
2011
Annual accounts 201110,2 k €↓
2010
Annual accounts 201043,3 k €↑
2009
Annual accounts 200932,5 k €↓
2008
Annual accounts 2008109,2 k €↑
2007
Annual accounts 2007-66 k €↓
2006
Annual accounts 2006-47,1 k €
29/05/1998
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

LOUVIMAR

Overview

What does LOUVIMAR do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline